Zobrazeno 1 - 5 of 5 pro vyhledávání: '"Borlenghi, CE"'
2
Akademický článek
Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies.
Autor: Baraliakos X; Rheumazentrum Ruhrgebiet, Ruhr University Bochum, Claudiusstrasse 45, 44649, Bochum, Herne, Germany. xenofon.baraliakos@elisabethgruppe.de., Szumski AE; Syneos Health, Princeton, NJ, USA., Kwok KK; Pfizer, New York, NY, USA., Vlahos B; Pfizer, Collegeville, PA, USA., Borlenghi CE; Pfizer, Buenos Aires, Argentina.
Publikováno v: Rheumatology and therapy [Rheumatol Ther] 2024 Jun; Vol. 11 (3), pp. 583-597. Date of Electronic Publication: 2024 Mar 15.
Zobrazit plný text záznamu
3
Akademický článek
Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis.
Autor: Citera G; Instituto de Rehabilitación Psicofísica, Echeverría 955, Buenos Aires, Argentina. gustavocitera@gmail.com., Bautista-Molano W; Universidad Militar Nueva Granada and University Hospital Fundación Santa Fe de Bogotá, Bogotá, Colombia., Peláez-Ballestas I; Hospital General de México 'Dr. Eduardo Liceaga', Mexico City, Mexico., Azevedo VF; Universidade Federal do Paraná, Curitiba, Brazil., Perich RA; Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru., Méndez-Rodríguez JA; Hospital La Católica, Guadalupe, San José, Costa Rica., Cutri MS; Pfizer, Buenos Aires, Argentina., Borlenghi CE; Pfizer, Buenos Aires, Argentina.
Publikováno v: Advances in rheumatology (London, England) [Adv Rheumatol] 2021 Jan 08; Vol. 61 (1), pp. 2. Date of Electronic Publication: 2021 Jan 08.
Zobrazit plný text záznamu
4
Akademický článek
Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial.
Autor: Zerbini CAF; Centro Paulista de Investigação Clínica, São Paulo, Brazil Hospital Central and Faculty of Medicine, Universidad Autónoma de San Luis Potosí, San Luis, Mexico Universidad de los Andes and Hospital Universitario Fundación Santafe de Bogotá, Bogotá, Colombia Pfizer, São Paulo, Brazil Pfizer, Collegeville, Pennsylvania, USA Pfizer, Buenos Aires, Argentina., Abud-Mendoza C, Mendez-Patarroyo P, De Angelo Andrade M, Pedersen R, Vlahos B, Borlenghi CE
Publikováno v: Medicine [Medicine (Baltimore)] 2018 Sep; Vol. 97 (36), pp. e11989.
Zobrazit plný text záznamu
5
Akademický článek
Incidence of Antidrug Antibodies in Rheumatoid Arthritis Patients From Argentina Treated With Adalimumab, Etanercept, or Infliximab in a Real-World Setting.
Autor: Maid PJ, Xavier R; Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Real RM; Pfizer, Collegeville, PA., Pedersen R; Pfizer, Collegeville, PA., Shen Q; Pfizer, Collegeville, PA., Marshall L; Pfizer, Collegeville, PA., Solano G; Pfizer, San José, Costa Rica., Borlenghi CE; Pfizer, Buenos Aires, Argentina., Hidalgo RP; Clínica Enfermedades Reumatoideas San Juan, San Juan, Argentina.
Publikováno v: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases [J Clin Rheumatol] 2018 Jun; Vol. 24 (4), pp. 177-182.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje